Bio-Rad Laboratories (BIO) Return on Equity (ROE)
Market Cap: $7.01B
Avg Volume: 356.48K
Industry: Medical - Devices
Sector: Healthcare
Return on Equity (ROE) Summary
Bio-Rad Laboratories's ROE measures the return generated on shareholders' equity:
- Annual: -28.07%
- Quarterly: -10.90%
- TTM: -24.68%
What is Return on Equity (ROE)?
Return on Equity measures a company's ability to generate profits from its shareholders' equity. It indicates how effectively the management is using the company’s assets to create profits. A higher ROE generally reflects well on the company’s management and its ability to generate profits without needing as much capital.
Related Metrics
Other important metrics to assess Bio-Rad Laboratories's profitability include:
- ROIC (Return on Invested Capital) - measures how effectively the company uses its invested capital to generate profits:
- Annual: 3.29%
- Quarterly: 0.51%
- TTM: 2.42%
- ROA (Return on Assets) - measures the return generated on the company's assets:
- Annual: -19.69%
- Quarterly: -7.64%
- TTM: -19.69%
- Profit Margin - indicates the profitability of the company relative to its revenue:
- Annual: -71.86%
- Quarterly: -107.24%
- TTM: -71.86%
These metrics provide insights into Bio-Rad Laboratories's profitability and efficiency in using its capital and assets to generate returns. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
Annual ROE
-28.07%
Quarterly ROE
-10.90%
TTM ROE
-24.68%
Bio-Rad Laboratories Historical ROE
Historical ROIC
Historical ROA
Bio-Rad Laboratories Historical Profitability Metrics
The table below shows various profitability metrics for each year, with the latest data available for the last fiscal year 2024.
| Year | ROE | ROIC | ROA | Profit Margin |
|---|---|---|---|---|
| 2024 | -28.07% | 3.29% | -19.69% | -71.86% |
| 2023 | -7.29% | 2.14% | -5.18% | -23.86% |
| 2022 | -37.73% | 2.87% | -26.87% | -129.45% |
| 2021 | 31.13% | 2.23% | 23.93% | 145.57% |
| 2020 | 38.61% | 2.57% | 29.40% | 149.83% |
| 2019 | 30.56% | 2.36% | 21.96% | 76.08% |
| 2018 | 8.99% | -1.50% | 6.44% | 15.76% |
| 2017 | 3.92% | 3.63% | 2.69% | 5.31% |
| 2016 | 1.09% | 1.07% | 0.73% | 1.36% |
| 2015 | 4.54% | 4.11% | 3.05% | 5.60% |
Related Metrics
Explore detailed financial metrics and analysis for BIO.